clinical trial · NCT05044819
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis ComplexCannabidiol
brief summary
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.
started
Jul 7, 2021
primary completion
Aug 1, 2027
completion
Mar 31, 2028
last updated
Apr 22, 2026
official title
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol